Sara Herrero-Gutierrez

Salamanca, CL, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial.

Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial.

Journal: The Lancet. Haematology

Published: October 06, 2025

Impact of the kinetics of circulating anti-BCMA CAR-T cells and normal lymphocytes on the outcome of MM patients.

Impact of the kinetics of circulating anti-BCMA CAR-T cells and normal lymphocytes on the outcome of MM patients.

Journal: HemaSphere

Published: April 10, 2025

Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients.

Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients.

Journal: Blood cancer journal

Published: February 26, 2024

Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy.

Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 24, 2023

Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts.

Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts.

Journal: Journal for immunotherapy of cancer

Published: May 08, 2021

C3G contributes to platelet activation and aggregation by regulating major signaling pathways.

C3G contributes to platelet activation and aggregation by regulating major signaling pathways.

Journal: Signal transduction and targeted therapy

Published: July 29, 2019

C3G, through its GEF activity, induces megakaryocytic differentiation and proplatelet formation.

C3G, through its GEF activity, induces megakaryocytic differentiation and proplatelet formation.

Journal: Cell communication and signaling : CCS

Published: September 25, 2018

C3G promotes a selective release of angiogenic factors from activated mouse platelets to regulate angiogenesis and tumor metastasis.

C3G promotes a selective release of angiogenic factors from activated mouse platelets to regulate angiogenesis and tumor metastasis.

Journal: Oncotarget

Published: July 05, 2017

NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.

NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 17, 2014

C3G forms complexes with Bcr-Abl and p38α MAPK at the focal adhesions in chronic myeloid leukemia cells: implication in the regulation of leukemic cell adhesion.

C3G forms complexes with Bcr-Abl and p38α MAPK at the focal adhesions in chronic myeloid leukemia cells: implication in the regulation of leukemic cell adhesion.

Journal: Cell communication and signaling : CCS

Published: July 31, 2012

C3G transgenic mouse models with specific expression in platelets reveal a new role for C3G in platelet clotting through its GEF activity.

C3G transgenic mouse models with specific expression in platelets reveal a new role for C3G in platelet clotting through its GEF activity.

Journal: Biochimica et biophysica acta

Published: November 02, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026